Ophthalmic solution
AssigneeNof Corporation
InventorsShunsuke Sakurai, Koji Miyamoto, Yohei Takada, Yoshihisa Shimamura, Mao Maruhashi, Nobuyuki Sakamoto
Life of this patent
Estimating the term…
Loading patent…
AssigneeNof Corporation
InventorsShunsuke Sakurai, Koji Miyamoto, Yohei Takada, Yoshihisa Shimamura, Mao Maruhashi, Nobuyuki Sakamoto
Estimating the term…
Provided is an ophthalmic solution of which preservative component, hexamethylene biguanide, contained therein is inhibited from being adsorbed on soft contact lenses and eye droppers. The ophthalmic solution contains, at a specific ratio, (A) hydroxypropyl methylcellulose having 28.0 to 30.0 mass % methoxy groups and 7.0 to 12.0 mass % hydroxypropoxy groups, both with respect to the total amount of the hydroxypropyl methylcellulose, at a methoxy group/hydroxypropoxy group ratio of 2.5 to 4.0 by mass, wherein a 2 mass % aqueous solution of the hydroxypropyl methylcellulose at 20° C. has a viscosity of 50 to 4000 mPa·s; (B) sodium chloride or potassium chloride; (C) hexamethylene biguanide or a salt thereof; (D) 2-methacryloyloxyethyl phosphorylcholine/butyl methacrylate copolymer; and (E) water.
An ophthalmic solution consisting of:
Dependencies are inferred from the claim text.